Global Wealth Strategies & Associates’s Verona Pharma VRNA Stock Holding History

Global Wealth Strategies & Associates’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-83	Closed	-$8.86K	–	601
2025 Q3	$8.86K	Hold	83	–	–	﹤0.01%	301
2025 Q2	$7.85K	Buy	83 +10	+14%	+$740	﹤0.01%	238
2025 Q1	$4.63K	Buy	+73	New	+$4.37K	﹤0.01%	324

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Global Wealth Strategies & Associates's VRNA Position: Q4 2025 in Review

Global Wealth Strategies & Associates sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 83 shares — an estimated $8.86K sold.

Global Wealth Strategies & Associates first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $8.86K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Global Wealth Strategies & Associates reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Global Wealth Strategies & Associates sold 83 Verona Pharma shares in Q4 2025, an estimated $8.86K.
Global Wealth Strategies & Associates first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
Global Wealth Strategies & Associates's Verona Pharma position peaked at $8.86K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Global Wealth Strategies & Associates's 13F filing for Q4 2025, filed 2 Jan 2026.